Patents Assigned to GlycoTech Corp.
  • Pharmaceutical compositions for treatment of EGF receptor associated cancers
    Patent number: 6281202
    Abstract: The present invention discloses carbohydrates and carbohydrate analogs that bind to epidermal growth factor (EGF) receptors. Methods of using such carbohydrates or analogs for a variety of uses related to the EGF receptor are also provided. In preferred aspects of the present invention, methods for killing or inhibiting the growth of tumor cells with increased EGF receptor activity are disclosed.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: August 28, 2001
    Assignee: GlycoTech Corp.
    Inventors: John L. Magnani, Eric G. Bremer
  • Sialyl-Lewisa and sialyl-Lewisx epitode analogues
    Patent number: 6187754
    Abstract: Sialyl-Lewisa and sialyl-Lewisx epitope analogues, in which the natural N-acetyl group of the N-acetylglucosamine monomer is replaced by various hydroxylated aromatic substituents.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: February 13, 2001
    Assignee: GlycoTech Corp.
    Inventor: Reinhold Oehrlein
  • Sialyl-Lewisa and sialyl-Lewisx epitope analogues
    Patent number: 6169077
    Abstract: Sialyl-Lewisx and sialyl-Lewisa epitope analogues in which the naturally occurring N-acetyl group of the N-acetylglucosamine monomer is replaced by various aliphatic or aromatic substituents and the L-fucose naturally present is replaced by various naturally occurring or non-naturally occurring sugars.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: January 2, 2001
    Assignee: GlycoTech Corp.
    Inventor: Reinhold Oehrlein
  • Methods for treatment of EGF receptor associated cancers
    Patent number: 6008203
    Abstract: The present invention discloses carbohydrates and carbohydrate analogs that bind to epidermal growth factor (EGF) receptors. Methods of using such carbohydrates or analogs for a variety of uses related to the EGF receptor are also provided. In preferred aspects of the present invention, methods for killing or inhibiting the growth of tumor cells with increased EGF receptor activity are disclosed.
    Type: Grant
    Filed: July 12, 1996
    Date of Patent: December 28, 1999
    Assignee: GlycoTech Corp.
    Inventors: John L. Magnani, Eric G. Bremer